Alemtuzumab and PEG3350
Determining the interaction of Alemtuzumab and PEG3350 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: n.a.
Generic Name: polyethylene glycol 3350
Brand name: ClearLax, GaviLAX, Gialax, GlycoLax, MiraLAX, PEG3350, SunMark ClearLax, GaviLAX, MiraLAX, HealthyLax
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab-Pegademase bovine
- Alemtuzumab-Pegademase Bovine Injection
- Alemtuzumab-Pegademase bovine Intramuscular
- Alemtuzumab-Peganone
- Alemtuzumab-Pegaptanib
- Alemtuzumab-Pegaptanib Intraocular
- PEG3350-Alemtuzumab (Campath)
- PEG3350-Alemtuzumab (Lemtrada)
- PEG3350-Alemtuzumab Intravenous
- PEG3350-Alenaze-D
- PEG3350-Alendronate
- PEG3350-Alendronate and cholecalciferol